Zobrazeno 1 - 10
of 152
pro vyhledávání: '"K. Abbrederis"'
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 108:623-626
Normal coronary vessels and an akinetic anterolateral wall segment were found in a 24-year-old patient on angiography 10 months after a clinically established myocardial infarction. As the patient had been on a high-dosage medication with ergotamine
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 110:1063-1067
The continuous subcutaneous infusion of opiate, a new approach to the alleviation of severe chronic pain, has been carried out using a pump system normally employed for the infusion of insulin. Relapses of pain can be controlled with bolus doses. Thi
Autor:
T. Fluckinger, G. Gastl, G. Michlmayr, Christoph Duba, D. Niederwieser, J. Thaler, Heinz Huber, I. Schiller, K. Abbrederis, A. Lang, Thomas Kühr, H. Gadner, R. Weitgasser, Georg Kemmler, C. Gattringer, C. Huber, H. Seewann, W. Fereberger, Michael A. Fridrik, Hubert Hausmaninger
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 116:721-728
In a Phase II study, 82 patients with Philadelphia chromosome(Ph)-positive chronic myelogenous leukaemia were treated with 3.5 million I.U./d of recombinant interferon alpha-2c (rIFN). 73 patients have so far been evaluated (42 male, 31 female, mean
Publikováno v:
Der Chirurg. 79:351-355
Bevacizumab (Avastin®) ist ein humanisierter monoklonaler Antikorper, der gegen den vaskularen endothelialen Wachstumsfaktor (VEGF-A) gerichtet ist. Bevacizumab fuhrt in Kombination mit Chemotherapie zu einer Verbesserung des Ansprechens und einer V
Publikováno v:
MMW Fortschritte der Medizin. 152
Autor:
K, Abbrederis, S, Lorenzen, L Fischer, von Weikersthal, U, Vehling-Kaiser, T, Schuster, N, Rothling, C, Peschel, F, Lordick
Publikováno v:
Critical reviews in oncology/hematology. 66(1)
Three-weekly docetaxel is active in patients with advanced esophagogastric cancer but myelosuppression may make this schedule unsuitable for some patient groups such as elderly, pretreated, or poor performance status patients.Eligible patients were c
Publikováno v:
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen. 79(4)
Bevacizumab (Avastin) is a monoclonal antibody against vascular endothelial growth factor (VEGF) receptor that has demonstrated increased overall survival when added to standard chemotherapy regimens in patients with metastatic colorectal cancer. Gas
Publikováno v:
Der Urologe. Ausg. A. 41(4)
Supernumerary kidney is a rare renal anomaly. As a distinct encapsulated parenchymatous mass, this free accessory organ has a separate blood supply and excretory duct system. We report on a patient who presented with an acute episode of abdominopelvi
Publikováno v:
Der Chirurg; Apr2008, Vol. 79 Issue 4, p351-355, 5p
Publikováno v:
Der Urologe A. 41:362-363
Supernumerary kidney is a rare renal anomaly. As a distinct encapsulated parenchymatous mass, this free accessory organ has a separate blood supply and excretory duct system. We report on a patient who presented with an acute episode of abdominopelvi